Ingenuity® Canonical Pathways | P-value | % DE# | Genes |
---|---|---|---|
Factors Promoting Cardiogenesis in Vertebrates | 0.0021 | 8.51 | TGFBR2, CCNE1, TGFB2, LEF1, TCF7L1, APC, PRKD1, CDK2 |
Antiproliferative Role of TOB in T Cell Signalling | 0.0047 | 15.4 | TGFBR2, CCNE1,TGFB2, CDK2 |
Alanine and Aspartate Metabolism | 0.0061 | 5.68 | ADSL, ASNSD1, DARS, MYO5B, ASNS |
HIF1α Signalling | 0.0066 | 7.27 | MAPK8, MRAS, KRAS, MMP2, HIF1A, MMP24, NOS2, P4HTM |
Nicotinate and Nicotinamide Metabolism | 0.018 | 5.15 | NT5C3, DAPK1, ENPP1, NEK2, MAPK8, MAK, CDK2 |
Apoptosis Signalling | 0.025 | 6.67 | CAPNS1, MAPK8, MRAS, KRAS, MAP4K4, PARP1 |
PPARα/RXRα Activation | 0.031 | 5 | TGFBR2, GPD1, MAPK8, MRAS, TGFB2, KRAS, MAP4K4, CYP2C19, ITGB5 |
Arachidonic Acid Metabolism | 0.037 | 3.57 | PLA2G4A, GPX3, CYP4B1, GPX5, ALOX12, CYP2C19, GPX6, PLOD3 |
Nitrogen Metabolism | 0.039 | 3.01 | CA9, CA3, ASNSD1, ASNS |
Prolactin Signalling | 0.039 | 6.49 | SOCS3, SP1, MRAS, KRAS, PRKD1 |
p38 MAPK Signalling | 0.043 | 6.25 | TGFBR2, PLA2G4A, DDIT3, TGFB2, CREB3L4, HMGN1 |
ATM Signalling | 0.047 | 7.55 | CCNB1, MAPK8, CREB3L4, CDK2 |
NF-κB Activation by Viruses | 0.048 | 6.00 | CR2, ITGB5, KRAS, MRAS, PRKD1 |
Intrinsic Prothrombin Activation Pathway | 0.049 | 8.60 | COL3A1, COL5A3, PROS1 |
HGF Signalling | 0.049 | 5.71 | MAPK8, MRAS, KRAS, MAP3K3, PRKD1, CDK2 |
TGF-β Signalling | 0.054 | 6.00 | KRAS, MAPK8, MRAS, TGFB2, TGFBR2 |